AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12099919 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 477
Study 10574417 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (n = 32)
Number of subjects: 57
Study 10574417 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 25)
Number of subjects: 57
Study 10574417 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Pravastatin vs Placebo
Number of subjects: 57
Study 8918516 — intervention group
Group type: EXPERIMENTAL
Intervention: Al(OH)3 (one tablet three times a day, about 302 mg aluminium day‐1) for 3 months
Number of subjects: 70
Study 8918516 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 patients receiving no Al‐containing agents)
Number of subjects: 70
Study 1907681 — intervention group
Group type: EXPERIMENTAL
Intervention: Vivonex TEN (unflavored)
Number of subjects: 10
Study 1907681 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensure
Number of subjects: 10
Study 1907681 — intervention group
Group type: COMPARATOR
Intervention: phenytoin suspension alone
Number of subjects: 10
Study 6440313 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliclazide 40 mg
Number of subjects: 277
Study 6440313 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide 2.5 mg
Number of subjects: 277
Study 30807455 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 528
Study 30807455 — intervention group
Group type: COMPARATOR
Intervention: Observational treatment
Number of subjects: 528
Study 30807455 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Antibiotic and Observational)
Number of subjects: 528
Study 29968187 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate vitamin D group (AVD; serum 25(OH)D > 50 nmol/l)
Number of subjects: 50
Study 29968187 — intervention group
Group type: COMPARATOR
Intervention: Inadequate vitamin D group (IVD; serum 25(OH)D < 50 nmol/l)
Number of subjects: 50
Study 29968187 — intervention group
Group type: EXPERIMENTAL
Intervention: OAGB surgery
Number of subjects: 50
Study 29968187 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D concentrations
Number of subjects: 50
Study 26889974 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent chemotherapy
Number of subjects: 1630
Study 26889974 — intervention group
Group type: COMPARATOR
Intervention: Continuous chemotherapy
Number of subjects: 1630
Study 25153791 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) at 20 and 30 Hz
Number of subjects: 40
Study 25153791 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) at 40 and 50 Hz
Number of subjects: 40
Study 25153791 — intervention group
Group type: COMPARATOR
Intervention: Nonvibration (0 Hz)
Number of subjects: 40
Study 22960817 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin 5% cream as single application
Number of subjects: 315
Study 22960817 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ivermectin 1% lotion as single application
Number of subjects: 315
Study 22960817 — intervention group
Group type: COMPARATOR
Intervention: Oral ivermectin 200 mcg/kg as single dose
Number of subjects: 315
Study 20960535 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with rosuvastatin (R) 5, 10, or 20 mg + fenofibric acid (FA) 135 mg
Number of subjects: 401
Study 20960535 — intervention group
Group type: COMPARATOR
Intervention: Fenofibric acid (FA) monotherapy
Number of subjects: 401
Study 20960535 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin (R) monotherapy
Number of subjects: 401
Study 17363756 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate CR (175 mg/day)
Number of subjects: 111
Study 17363756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 15712850 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse wheat bran (10-20 g/day)
Number of subjects: 28
Study 15712850 — intervention group
Group type: COMPARATOR
Intervention: Low fibre placebo
Number of subjects: 28
Study 12577231 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy with radiation and 5-fluorouracil
Number of subjects: 0
Study 12577231 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine as first-line treatment
Number of subjects: 0
Study 12577231 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapies with gemcitabine
Number of subjects: 0
Study 12577231 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined-modality approaches with gemcitabine and radiation
Number of subjects: 0
Study 11334066 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (10 mg/kg IV)
Number of subjects: 74
Study 11334066 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 74
Study 11334066 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (additional doses)
Number of subjects: 74
Study 11334066 — intervention group
Group type: COMPARATOR
Intervention: Placebo (additional doses)
Number of subjects: 74
Study 9727545 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine (500 mg daily)
Number of subjects: 20
Study 9727545 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (325 mg daily)
Number of subjects: 20
Study 9727545 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Ticlopidine and Aspirin)
Number of subjects: 20
Study 8052456 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice cocktail (300 mL daily)
Number of subjects: 100
Study 8052456 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study 2660603 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care case management
Number of subjects: 0
Study 2660603 — intervention group
Group type: COMPARATOR
Intervention: Traditional Medicaid programs (comparison group)
Number of subjects: 0
Study 1099915 — intervention group
Group type: EXPERIMENTAL
Intervention: Idoxuridine (IDU)
Number of subjects: 112
Study 1099915 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenine arabinoside (ara-A)
Number of subjects: 112
Study 581856 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression bandage with a plaster cylinder, weight-bearing allowed with crutches, discharged after four days in hospital.
Number of subjects: 80
Study 581856 — intervention group
Group type: COMPARATOR
Intervention: Traditional method of a compression bandage with a backsplint, followed by a 10-day stay in hospital.
Number of subjects: 80
Study 31307654 — intervention group
Group type: EXPERIMENTAL
Intervention: RC-LE (reversed hanging protocol)
Number of subjects: 27
Study 31307654 — intervention group
Group type: COMPARATOR
Intervention: LE-RC (commonly used hanging protocol)
Number of subjects: 27
Study 31307654 — intervention group
Group type: COMPARATOR
Intervention: FFDM (Full-Field Digital Mammography)
Number of subjects: 27
Study 29923298 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi (fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide)
Number of subjects: 0
Study 29923298 — intervention group
Group type: COMPARATOR
Intervention: Lixisenatide alone
Number of subjects: 0
Study 29923298 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0
Study 26907339 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dairy Intake (HD)
Number of subjects: 0
Study 26907339 — intervention group
Group type: COMPARATOR
Intervention: Low Dairy Intake (LD)
Number of subjects: 0
Study 26907339 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-restricted intervention
Number of subjects: 0
Study 26907339 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet effect
Number of subjects: 0
Study 24931923 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal prong oxygen
Number of subjects: 24
Study 24931923 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaesthesia machine flush oxygen
Number of subjects: 24
Study 24931923 — intervention group
Group type: COMPARATOR
Intervention: Standard pre-oxygenation with a simulated facemask leak
Number of subjects: 24
Study 22725648 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1 mg/kg bolus, followed by continuous infusion of 20 μg/kg/min after intubation)
Number of subjects: 105
Study 22725648 — intervention group
Group type: EXPERIMENTAL
Intervention: IV flurbiprofen (1 mg/kg before skin incision)
Number of subjects: 105
Study 22725648 — intervention group
Group type: EXPERIMENTAL
Intervention: IV parecoxib (40 mg before skin incision)
Number of subjects: 105
Study 22725648 — intervention group
Group type: COMPARATOR
Intervention: Control (sevoflurane only)
Number of subjects: 105
Study 21165295 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus (Lacidofil® cap)
Number of subjects: 214
Study 21165295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study 18056558 — intervention group
Group type: EXPERIMENTAL
Intervention: Buckwheat honey
Number of subjects: 105
Study 18056558 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey-flavored dextromethorphan (DM)
Number of subjects: 105
Study 18056558 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 105
Study 16132930 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib mesylate treatment
Number of subjects: 45
Study 11834117 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise training with 3 sets at approximately 50% 1RM and 30 seconds interset rest, performed twice a week for 12 weeks.
Number of subjects: 10
Study 10071990 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (continuous i.v. beta-blockade)
Number of subjects: 26
Study 10071990 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus usual medical therapy
Number of subjects: 26
Study 7899948 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial interventions (specific interventions not detailed)
Number of subjects: 325
Study 7899948 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher median family income
Number of subjects: 325
Study 7899948 — intervention group
Group type: EXPERIMENTAL
Intervention: Being disabled from working
Number of subjects: 325
Study 7899948 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance from hospital (moderate)
Number of subjects: 325
Study 1903319 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nutrition
Number of subjects: 18
Study 1903319 — intervention group
Group type: COMPARATOR
Intervention: Fasted group
Number of subjects: 18
Study 1903319 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro rates of protein synthesis with fed serum
Number of subjects: 18
Study 1903319 — intervention group
Group type: COMPARATOR
Intervention: In vitro rates of protein synthesis with fasted serum
Number of subjects: 18
Study 6781888 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 33
Study 6781888 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 33
Study 30813149 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (GLN) supplementation at a dose of 10g every 8 hours (prophylactic powdered GLN orally)
Number of subjects: 60
Study 30813149 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (GLN) supplementation
Number of subjects: 60
Study 31038033 — intervention group
Group type: EXPERIMENTAL
Intervention: Short sleep duration (5-6 hours)
Number of subjects: 237
Study 31038033 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 237
Study 31038033 — intervention group
Group type: COMPARATOR
Intervention: Diet quality indices
Number of subjects: 237
Study 26450442 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy (robot-assisted therapy plus intensive conventional therapy)
Number of subjects: 127
Study 26450442 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 127
Study 23957932 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing music
Number of subjects: 93
Study 23957932 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral music
Number of subjects: 93
Study 23957932 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressful music
Number of subjects: 93
Study 23957932 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 93
Study 23957932 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleasant music (regardless of type)
Number of subjects: 93
Study 22428942 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 203
Study 22428942 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 203
Study 22428942 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 203
Study 22428942 — intervention group
Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 203
Study 18353529 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen velocity (PSAV)
Number of subjects: 2217
Study 18353529 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of PSAV cut-offs
Number of subjects: 2217
Study 17957152 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (2.2 g DHA and 1.1 g EPA)
Number of subjects: 98
Study 17957152 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 98
Study 17957152 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 98
Study 15891550 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (closed reduction and percutaneous pin fixation, open reduction and internal fixation, and arthrodesis)
Number of subjects: 0
Study 15891550 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (elevation, ice, early mobilization, cyclic compression of the plantar arch)
Number of subjects: 0
Study 11812816 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational campaign
Number of subjects: 187
Study 11812816 — intervention group
Group type: COMPARATOR
Intervention: Malathion spraying
Number of subjects: 187
Study 11812816 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both treatments
Number of subjects: 187
Study 11812816 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 187
Study 9987151 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal mucosal vaccine for UTI
Number of subjects: 47
Study 9987151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 7590584 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic surgery
Number of subjects: 0
Study 7590584 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 0
Study 2279255 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibopamine
Number of subjects: 247
Study 2279255 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 247
Study 2279255 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibopamine plus HCTZ
Number of subjects: 247
Study 2279255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study 384815 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole treatment
Number of subjects: 341
Study 384815 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 341
Study 31278815 — intervention group
Group type: EXPERIMENTAL
Intervention: Moog Simodont dental trainer (VR)
Number of subjects: 32
Study 31278815 — intervention group
Group type: COMPARATOR
Intervention: No exposure to VR (Control)
Number of subjects: 32
Study 30440120 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive DNA examination
Number of subjects: 544
Study 30440120 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced labor due to confirmed chromosome abnormality
Number of subjects: 544
Study 30440120 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (positive soft markers)
Number of subjects: 544
Study 30440120 — intervention group
Group type: COMPARATOR
Intervention: Group B (no obvious abnormalities)
Number of subjects: 544
Study 27769585 — intervention group
Group type: EXPERIMENTAL
Intervention: New regression formula for predicting postoperative ACD using ATA depth, preoperative ACD, and axial length (AL).
Number of subjects: 304
Study 27769585 — intervention group
Group type: COMPARATOR
Intervention: Sanders‐Retzlaff‐Kraff theoretic (SRK/T) formula.
Number of subjects: 304
Study 27769585 — intervention group
Group type: COMPARATOR
Intervention: Haigis formula.
Number of subjects: 304
Study 25386795 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical diagnostic blood test
Number of subjects: 153
Study 25386795 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodule size
Number of subjects: 153
Study 25386795 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of patients
Number of subjects: 153
Study 25386795 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking history
Number of subjects: 153
Study 23227678 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 192
Study 23227678 — intervention group
Group type: COMPARATOR
Intervention: Nimodipine
Number of subjects: 192
Study 20212201 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazolidinediones
Number of subjects: 9690
Study 20212201 — intervention group
Group type: COMPARATOR
Intervention: Retinopathy severity
Number of subjects: 9690
Study 20212201 — intervention group
Group type: COMPARATOR
Intervention: Age
Number of subjects: 9690
Study 20212201 — intervention group
Group type: COMPARATOR
Intervention: Hemoglobin A(1c)
Number of subjects: 9690
Study 20212201 — intervention group
Group type: COMPARATOR
Intervention: Duration of diabetes
Number of subjects: 9690
Study 20212201 — intervention group
Group type: COMPARATOR
Intervention: Sex
Number of subjects: 9690
Study 20212201 — intervention group
Group type: COMPARATOR
Intervention: Ethnicity
Number of subjects: 9690
Study 18803532 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day course of oral prednisolone (1 mg/kg)
Number of subjects: 201
Study 18803532 — intervention group
Group type: COMPARATOR
Intervention: 3-day course of prednisolone plus placebo for 2 days
Number of subjects: 201
Study 16197587 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (100 microg for 6 weeks followed by 200 microg for a further 6 weeks)
Number of subjects: 23
Study 12392333 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up home visits by a physician
Number of subjects: 155
Study 12392333 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist instruction in the patient's home
Number of subjects: 155
Study 12392333 — intervention group
Group type: COMPARATOR
Intervention: Standard aftercare
Number of subjects: 155
Study 10201583 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial medications (n=307) with a stepped regimen to lower intraocular pressure
Number of subjects: 607
Study 10201583 — intervention group
Group type: COMPARATOR
Intervention: Immediate filtration surgery (n=300) with trabeculectomy to lower intraocular pressure
Number of subjects: 607
Study 10201583 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial medications (n=307)
Number of subjects: 607
Study 10201583 — intervention group
Group type: COMPARATOR
Intervention: Immediate filtration surgery (n=300)
Number of subjects: 607
Study 7776933 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 micrograms BDP plus 800 micrograms salbutamol
Number of subjects: 24
Study 7776933 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus 800 micrograms salbutamol
Number of subjects: 24
Study 2149017 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, 2.8 micrograms/kg per day)
Number of subjects: 30
Study 2149017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 95609 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylase-creatinine clearance ratio
Number of subjects: 0
Study 95609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fraction of pancreatic isoamylase in serum
Number of subjects: 0
Study 31126631 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline in combination with oral corticosteroids for 20 days
Number of subjects: 49
Study 31126631 — intervention group
Group type: COMPARATOR
Intervention: Placebo in combination with oral corticosteroids for 20 days
Number of subjects: 49
Study 28347493 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound (TVUS)
Number of subjects: 120
Study 28347493 — intervention group
Group type: COMPARATOR
Intervention: Conventional transabdominal ultrasound (TAUS)
Number of subjects: 120
Study 25925807 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 212
Study 25925807 — intervention group
Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 212
Study 25925807 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 212
Study 23726870 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) treatment for depression
Number of subjects: 139
Study 23726870 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted Hamilton Depression Rating Scale (HamD) score (omitting sleep items)
Number of subjects: 139
Study 21781066 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA
Number of subjects: 41
Study 21781066 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 41
Study 21781066 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 41
Study 21781066 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 41
Study 19346367 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental malaria (PM)
Number of subjects: 1662
Study 19346367 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment for maternal plasma viral load and CD4+ cell count
Number of subjects: 1662
Study 19346367 — intervention group
Group type: EXPERIMENTAL
Intervention: Low maternal plasma viral load
Number of subjects: 1662
Study 16824994 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak early diastolic strain rate (ESR)
Number of subjects: 25
Study 16824994 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak late diastolic strain rate
Number of subjects: 25
Study 16824994 — intervention group
Group type: EXPERIMENTAL
Intervention: Time from QRS to ESR
Number of subjects: 25
Study 16824994 — intervention group
Group type: COMPARATOR
Intervention: Flow propagation velocity
Number of subjects: 25